Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPA3 | P15088 | 1/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.50 |
| ▸ | MME | P08473 | 4/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1031027 | 1.00 | CPA3 (0.50) | CPA3FOLH1MMEGAAMAPT | |
| SCHEMBL515921 | 1.00 | CPA3 (0.50) | CPA3FOLH1MMEGAAMAPT | |
| Hydrochloric Acid SCHEMBL28182328 | 0.98 | CPA3 (0.49) | CPA3FOLH1MMEGAAMAPT | |
| Hydrochloric Acid SCHEMBL1927540 | 0.98 | CPA3 (0.49) | CPA3FOLH1MMEGAAMAPT | |
| Hydrochloric Acid SCHEMBL1927541 | 0.98 | CPA3 (0.49) | CPA3FOLH1MMEGAAMAPT | |
| Benzenemethanethiol SCHEMBL11584239 | 0.95 | IDO1 (0.47) | CPA3FOLH1MMEGAAMAPT | |
| SCHEMBL5505220 | 0.91 | MME (0.49) | MMEGAA | |
| Cysteine SCHEMBL1927883 | 0.91 | PTGS1 (0.49) | CPA3FOLH1MME | |
| SCHEMBL14777396 | 0.86 | MEN1 (0.46) | CPA3FOLH1MME | |
| SCHEMBL14935818 | 0.86 | FOLH1 (0.46) | CPA3FOLH1MMEGAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 670 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250339569-A1 | CARBONIC ANHYDRASE IX LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2025-11-06 | — | — | US | claimed |
| US-12441765-B2 | Peptides and medical uses thereof | ANBITION S.R.L. (IT) | 2025-10-14 | — | — | US | claimed |
| EP-4448544-A2 | CARBONIC ANHYDRASE IX LIGANDS | 3B Pharmaceuticals GmbH (DE) | 2024-10-23 | — | — | EP | claimed |
| CN-116120936-B | Etching liquid medicine and preparation method and application thereof | 上海天承化学有限公司 | 2024-06-25 | — | — | CN | claimed |
| WO-2024088181-A1 | LIGHT-EMITTING DEVICE AND PREPARATION METHOD THEREFOR, AND DISPLAY DEVICE | TCL科技集团股份有限公司 | 2024-05-02 | — | — | WO | claimed |
| CN-116655730-A | Derivatives of N-caproic acid-L-tyrosine-L-isoleucine- (6) -aminocaproamide for the treatment of various diseases | 雅斯娜 | 2023-08-29 | — | — | CN | claimed |
| WO-2023111350-A2 | CARBONIC ANHYDRASE IX LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2023-06-22 | — | — | WO | claimed |
| CN-116120936-A | Etching liquid medicine and preparation method and application thereof | 上海天承化学有限公司 | 2023-05-16 | — | — | CN | claimed |
| WO-2022162030-A1 | PEPTIDES FOR INHIBITING ANGIOGENESIS | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2022-08-04 | — | — | WO | claimed |
| CN-113880910-A | Preparation method of synthetic glutathione | 浙江恒腾福生物科技集团有限公司 | 2022-01-04 | — | — | CN | claimed |
| EP-0282219-A1 | Aminoethylphosphinic acid derivatives | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1988-09-14 | — | — | EP | claimed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | claimed |
| EP-0272671-A2 | Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors | SANDOZ LTD. (CH) | 1988-06-29 | — | — | EP | claimed |
| EP-0235064-A2 | Aromatic compounds with amide structure, derivatives of amino-benzoic acids, hydroxybenzoic acids, cinnamic acids, urocanic acids and benzimidazoles, absorbing UVB and/or UVA | Robert, Dominique (FR) | 1987-09-02 | — | — | EP | claimed |
| WO-1987004923-A2 | AROMATIC AMIDES ABSORBING THE U.V. | ROBERT DOMINIQUE | 1987-08-27 | — | — | WO | claimed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | claimed |
| EP-0076557-B1 | PEPTIDES AND PSEUDOPEPTIDES IN WHICH THE N TERMINUS BEARS TWO SUBSTITUENTS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-11-13 | — | — | EP | claimed |
| US-4483807-A | Process for producing a slow release composite | JAPAN ATOMIC ENERGY RESEARCH INSTITUTE (JP) | 1984-11-20 | — | — | US | claimed |
| US-4421744-A | OPIATE RECEPTOR ANTAGONISTS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1983-12-20 | — | — | US | claimed |
| US-3936469-A | Process for preparing N-carboxylic anhydrides of amino acids | KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JA) | 1976-02-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12441765-B2 | Peptides and medical uses thereof | FLT1, FLT4, TEK | CPA3 200/4885FOLH1 267/4885MME 182/4885 |
| US-20250339569-A1 | CARBONIC ANHYDRASE IX LIGANDS | CA9, CA13, CA4 | CPA3 43/4885FOLH1 36/4885MME 316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.